Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
20 Jun 2024
Historique:
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: epublish

Résumé

Autoimmune diseases of the central nervous system (CNS) such as multiple sclerosis (MS) are only partially represented in current experimental models and the development of humanized immune mice is crucial for better understanding of immunopathogenesis and testing of therapeutics. We describe a humanized mouse model with several key features of MS. Severely immunodeficient B2m-NOG mice were transplanted with peripheral blood mononuclear cells (PBMCs) from HLA-DRB1-typed MS and healthy (HI) donors and showed rapid engraftment by human T and B lymphocytes. Mice receiving cells from MS patients with recent/ongoing Epstein-Barr virus reactivation showed high B cell engraftment capacity. Both HLA-DRB1*15 (DR15) MS and DR15 HI mice, not HLA-DRB1*13 MS mice, developed human T cell infiltration of CNS borders and parenchyma. DR15 MS mice uniquely developed inflammatory lesions in brain and spinal cord gray matter, with spontaneous, hCD8 T cell lesions, and mixed hCD8/hCD4 T cell lesions in EAE immunized mice, with variation in localization and severity between different patient donors. Main limitations of this model for further development are poor monocyte engraftment and lack of demyelination, lymph node organization, and IgG responses. These results show that PBMC humanized mice represent promising research tools for investigating MS immunopathology in a patient-specific approach.

Identifiants

pubmed: 38900149
doi: 10.7554/eLife.88826
pii: 88826
doi:
pii:

Substances chimiques

HLA-DRB1 Chains 0
HLA-DRB1*15 antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Hellenic Ministry of Development and Investment
ID : T1EDK-01859
Organisme : Hellenic Ministry of Development and Investment
ID : 2018ΣΕ01300001

Informations de copyright

© 2023, Papazian et al.

Déclaration de conflit d'intérêts

IP, MK, AD, VG, LD, NM, FB, TT, MA, LP No competing interests declared

Auteurs

Irini Papazian (I)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.

Maria Kourouvani (M)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Athens International Master's Programme in Neurosciences, Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.

Anastasia Dagkonaki (A)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.

Vasileios Gouzouasis (V)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.

Lila Dimitrakopoulou (L)

Department of Hematology, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Markoglou (N)

Research Immunogenetics Laboratory, Multiple Sclerosis and Demyelinating Diseases Unit, First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, NKUA, Aeginition University Hospital, Athens, Greece.

Fotis Badounas (F)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Transgenic Technology Unit, Hellenic Pasteur Institute, Athens, Greece.

Theodore Tselios (T)

Department of Chemistry, University of Patras, Patras, Greece.

Maria Anagnostouli (M)

Research Immunogenetics Laboratory, Multiple Sclerosis and Demyelinating Diseases Unit, First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, NKUA, Aeginition University Hospital, Athens, Greece.

Lesley Probert (L)

Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH